Haematological Products

CARNUMAX

A cell-cycle phase nonspecific alkylating antineoplastic agent. It is a nitrogen mustard β-chloro-nitrosourea compound. It is used in the treatment of brain tumors and various other malignant neoplasms, Multiple myeloma, Hodgkin’s and Non-Hodgkin’s lymphoma.

DOXOGET

Doxorubicin is an anthracycline type of chemotherapy that is used alone or with other chemoagents to treat several different types of cancer.

BENDAMAX

Bendamustine hydrochloride is a bifunctional chemotherapeutic agent with structurally similar to alkylating agents and purine analogues.

LENAGET

Lenalidomideis an immunomodulatory drug and also thalidomide analogue, It was initially intended as a treatment for multiple myeloma,

BUSULMAX

Busulfan is a bifunctional alkylating agent, having a selective immunosuppressive effect on bone marrow. It has been used in the palliative treatment of Chronic Myeloid Leukemia (CML).

BORTIVA

Bortezomib is the first of its class to be approved for clinical use. It is a 26S proteosome inhibitor (26S proteosome is the principal regulator

DROXIGET

Hydroxyurea has constantly evolved as a drug ever since its initial approval in CML. The drug has been extensively studied in Acute Leukemias, Sickle Cell Anaemia

THALIMAX

Thalidomide can be compared with the Phoenix that rose from the ashes according to Greek Mythology. A drug that was banned 50 years ago after the infamous ‘thalidomide babies’ case.

MELFALAX

Melphalan is an indispensable part of Multiple Myeloma treatment. Being available in oral dosage form, it adds to the convenience of the patient, especially in ‘all oral’ chemotherapy regimens.


  • 1
  • 2